International Society For Pharmacoepidemiology
501C3 Nonprofit Organization Information
International Society For Pharmacoepidemiology is a 501(c)(3) charitable nonprofit in Washington, District Of Columbia (EIN 41-1688677). It has been tax-exempt since July 1994, and contributions to it are tax-deductible. Its Form 990 for tax year 2024 reports total revenue of $3,252,371 and net assets of $3,282,375. TaxExemptWorld has Form 990s on file for 17 tax years (2008–2024). It is one of 28,865 nonprofits in Washington, DC.
Form 990 · Tax period ending Jun 2025 · Filed May 14, 2026 · From the IRS e-file data
Dollar amounts for every revenue and expense line are in the full 990 report.
Mission (as filed): See Schedule O
Development and management of scientific forums: 1) convene an annual scientific forum (international conference on pharmacoepidemiology & therapeutic risk management - ICPE) where members of the discipline meet to network, present results of methodological investigations and studies in progress, discuss public health policy issues concerning pharmacoepidemiology, therapeutic risk management, and other related fields. 2) Convene regular regional and local meetings on scientific and public policy issues, which currently includes a mid-year conference in conjunction with meetings of the board o…
The Societys communications program delivers: 1) a website with significant resources on the expanding science and practice of pharmacoepidemiology, and presents ISPEs goals and objectives to current/prospective members, and the general public; and 2) regular email updates to members on developments in pharmacoepidemiology, or about ISPE.
Publications: 1) The Society provides a members-only subscription to Pharmacoepidemiology and Drug Safety, a leading scientific journal publishing definitive, peer-reviewed papers on the science and practice of pharmacoepidemiology; and 2) a Manuscript Initiative, which funds the development of resource documents focused on pharmacoepidemiology, pharmacovigilance, drug utilization research, outcomes research, comparative effectiveness research, and therapeutic risk management.
Membership: With membership of over 2000 in more than 50 countries, the Society is the voice of pharmacoepidemiology, pharmacovigilance, drug utilization research, outcomes research, comparative effectiveness research, and therapeutic risk management. Members gain access to a rich and formidable network of like-minded individuals entirely focused on these issues, combined with career mentoring and professional development.
Public charity (509(a)(2)) · 96.6% public support
Prepared by TaxExemptWorld from IRS Form 990 e-file data (object ID 202621359349312882). Not an official IRS form.